Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA5276245
Max Phase: Preclinical
Molecular Formula: C39H45ClN10O4S
Molecular Weight: 785.37
Associated Items:
ID: ALA5276245
Max Phase: Preclinical
Molecular Formula: C39H45ClN10O4S
Molecular Weight: 785.37
Associated Items:
Canonical SMILES: Cc1nc(Nc2ncc(C(=O)Nc3c(C)cccc3Cl)s2)cc(N2CCN(CCCC(=O)N3CCN(c4ccc(C5CCC(=O)NC5=O)cc4)CC3)CC2)n1
Standard InChI: InChI=1S/C39H45ClN10O4S/c1-25-5-3-6-30(40)36(25)46-38(54)31-24-41-39(55-31)44-32-23-33(43-26(2)42-32)49-17-15-47(16-18-49)14-4-7-35(52)50-21-19-48(20-22-50)28-10-8-27(9-11-28)29-12-13-34(51)45-37(29)53/h3,5-6,8-11,23-24,29H,4,7,12-22H2,1-2H3,(H,46,54)(H,45,51,53)(H,41,42,43,44)
Standard InChI Key: UVLQOVGDDSJYRQ-UHFFFAOYSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 785.37 | Molecular Weight (Monoisotopic): 784.3034 | AlogP: 4.97 | #Rotatable Bonds: 11 |
Polar Surface Area: 156.00 | Molecular Species: BASE | HBA: 12 | HBD: 3 |
#RO5 Violations: 2 | HBA (Lipinski): 14 | HBD (Lipinski): 3 | #RO5 Violations (Lipinski): 2 |
CX Acidic pKa: 8.49 | CX Basic pKa: 8.55 | CX LogP: 5.09 | CX LogD: 4.89 |
Aromatic Rings: 4 | Heavy Atoms: 55 | QED Weighted: 0.18 | Np Likeness Score: -1.67 |
1. Jarusiewicz JA, Yoshimura S, Mayasundari A, Actis M, Aggarwal A, McGowan K, Yang L, Li Y, Fu X, Mishra V, Heath R, Narina S, Pruett-Miller SM, Nishiguchi G, Yang JJ, Rankovic Z.. (2023) Phenyl Dihydrouracil: An Alternative Cereblon Binder for PROTAC Design., 14 (2.0): [PMID:36793425] [10.1021/acsmedchemlett.2c00436] |
Source(1):